18:1 LYSO PA

Code: 857130P-25MG D2-231

Application

18:1 Lyso PA or 1-oleoyl-2-hydroxy-sn-glycero-3-phosphate has been used: to study its effects on intracellular calcium concentration [Ca2+]itr...


 Read more

Your Price
€218.43 25MG
€268.67 inc. VAT

Application

18:1 Lyso PA or 1-oleoyl-2-hydroxy-sn-glycero-3-phosphate has been used: to study its effects on intracellular calcium concentration [Ca2+]itransient in pheochromocytoma cell 12 (PC12) cells and primary astrocytes. It has also been used to study its effects on blood glucose level and physical endurance in fasted mice.

Biochem/physiol Actions

Biological responses to LPA: Cell Proliferation, Inhibition of differentiation (neuroblastoma cells, myoblasts), Platelet aggregation, Smooth muscle contraction, Neurotransmitter release, Stress fibre formation/cell rounding/neurite retraction, Cell-surface-fibronectin binding, Tumor cell invasion, Chemotaxis (dictyostelium amoebae), Cl--mediated membrane depolarization (fibroblasts), Inhibition of connexin 43 based cell-cell communication, Increased tight junction permeability (brain endothelial cells). Note: The bioactivity of LPA appears to require long (i.e., C16 to C18) acyl carbon chains of the type usually found associated with membrane lipids although optimum requirements for a single type of acyl carbon chain are not universal. The bioactivity decreases with shorter chain length. In serum, oleoyl and palmitoyl fatty acid containing LPA are the predominant species.

General description

Lysophosphatidic acid (LPA)belongs to a class ofphospholipids, which hasa glycerol backbone attached through a phosphate group, an aliphatic chain and a hydroxyl group. The phosphate group is linked to the sn-3 position and the aliphatic chain is linked to either sn-1 or sn-2 position. The hydroxyl group is connected to the remaining sn-1 or sn-2 position.

Packaging

60 mL Amber Wide Mouth Screw Cap Glass Bottle (857130P-1g)

5 mL Clear Glass Sealed Ampule (857130P-200mg)

5 mL Clear Glass Sealed Ampule (857130P-25mg)

assay>99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
formpowder
manufacturer/tradenameAvanti Polar Lipids 857130P
packagingpkg of 1 × 1 g (857130P-1g), pkg of 2 × 100 mg (857130P-200mg), pkg of 1 × 25 mg (857130P-25mg)
shipped indry ice
SMILES stringO[C@](COP([O-])(O)=O)([H])COC(CCCCCCC/C=CCCCCCCCC)=O.[Na+]
storage temp.−20°C
Cas Number325465-93-8
This product has met the following criteria to qualify for the following awards:



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.